BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27279346)

  • 1. Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.
    Kypridemos C; Allen K; Hickey GL; Guzman-Castillo M; Bandosz P; Buchan I; Capewell S; O'Flaherty M
    BMJ; 2016 Jun; 353():i2793. PubMed ID: 27279346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated reductions in cardiovascular and gastric cancer disease burden through salt policies in England: an IMPACTNCD microsimulation study.
    Kypridemos C; Guzman-Castillo M; Hyseni L; Hickey GL; Bandosz P; Buchan I; Capewell S; O'Flaherty M
    BMJ Open; 2017 Jan; 7(1):e013791. PubMed ID: 28119387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.
    Mytton OT; Jackson C; Steinacher A; Goodman A; Langenberg C; Griffin S; Wareham N; Woodcock J
    PLoS Med; 2018 Mar; 15(3):e1002517. PubMed ID: 29509767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK.
    Kypridemos C; Collins B; McHale P; Bromley H; Parvulescu P; Capewell S; O'Flaherty M
    PLoS Med; 2018 May; 15(5):e1002573. PubMed ID: 29813056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calorie labelling in the out-of-home food sector on adult obesity prevalence, cardiovascular mortality, and social inequalities in England: a modelling study.
    Colombet Z; Robinson E; Kypridemos C; Jones A; O'Flaherty M
    Lancet Public Health; 2024 Mar; 9(3):e178-e185. PubMed ID: 38429017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations.
    Selvarajah S; Haniff J; Kaur G; Guat Hiong T; Bujang A; Chee Cheong K; Bots ML
    BMC Cardiovasc Disord; 2013 Feb; 13():10. PubMed ID: 23442728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
    Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling study.
    Guzman-Castillo M; Ahmed R; Hawkins N; Scholes S; Wilkinson E; Lucy J; Capewell S; O'Flaherty M
    BMJ Open; 2015 Jan; 5(1):e006070. PubMed ID: 25613952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.
    Barton P; Andronis L; Briggs A; McPherson K; Capewell S
    BMJ; 2011 Jul; 343():d4044. PubMed ID: 21798967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study.
    Baker J; Mitchell R; Lawson K; Pell J
    Heart; 2013 Dec; 99(23):1766-71. PubMed ID: 24092057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
    Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: A modelling study.
    Pearson-Stuttard J; Bandosz P; Rehm CD; Penalvo J; Whitsel L; Gaziano T; Conrad Z; Wilde P; Micha R; Lloyd-Williams F; Capewell S; Mozaffarian D; O'Flaherty M
    PLoS Med; 2017 Jun; 14(6):e1002311. PubMed ID: 28586351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study.
    Lang SJ; Abel GA; Mant J; Mullis R
    BMJ Open; 2016 Mar; 6(3):e009984. PubMed ID: 27000783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis.
    Collins B; Kypridemos C; Cookson R; Parvulescu P; McHale P; Guzman-Castillo M; Bandosz P; Bromley H; Capewell S; O'Flaherty M
    Prev Med; 2020 Jan; 130():105879. PubMed ID: 31678586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.
    Allen K; Pearson-Stuttard J; Hooton W; Diggle P; Capewell S; O'Flaherty M
    BMJ; 2015 Sep; 351():h4583. PubMed ID: 26374614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic status and health inequalities for cardiovascular prevention among elderly Spaniards.
    Mejía-Lancheros C; Estruch R; Martínez-González MA; Salas-Salvadó J; Corella D; Gómez-Gracia E; Fiol M; Lapetra J; Covas MI; Arós F; Serra-Majem L; Pintó X; Basora J; Sorlí JV; Muñoz MA;
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):803-11. PubMed ID: 24773861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the health and economic effects of the voluntary sodium reduction targets in Brazil: microsimulation analysis.
    Nilson EAF; Pearson-Stuttard J; Collins B; Guzman-Castillo M; Capewell S; O'Flaherty M; Jaime PC; Kypridemos C
    BMC Med; 2021 Sep; 19(1):225. PubMed ID: 34583695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 inequalities in England: a mathematical modelling study of transmission risk and clinical vulnerability by socioeconomic status.
    Goodfellow L; van Leeuwen E; Eggo RM
    BMC Med; 2024 Apr; 22(1):162. PubMed ID: 38616257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.
    Zomer E; Leach R; Trimmer C; Lobstein T; Morris S; James WP; Finer N
    Diabetes Obes Metab; 2017 Jan; 19(1):118-124. PubMed ID: 27649286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.